I see no benefit. And I see no connection to the B

I see no benefit. And I see no connection to the BOD comp plan passage. Maybe I'm missing something, but IMHO the EIND patient data validates the science of LL and it is the only near publication that I am aware of that does so. So, again why would NP shoot down the only real evidence for LL? I can't see that it would have any positive impact on Comp plan passage. Unless he just doesn't like BP and is willing to risk everything to "ruin" him? Sounds even more paranoid than many of the suggestions on this board. I am willing to learn more about "long term implications" but as the proof stands it's a ridiculous business strategy.